Rewriting human health,

one cell at a time

Empowering Biomedical innovation and a new generation of cures through deterministic cell programming

Cell coding platform

Our platform has the ability to create any human cell type and to manufacture it at scale with precision and consistency. 

bitbio-platform_diagram-horizontal-no_BG-min bitbio-platform_diagram-vertical-no_BG-min

Therapeutics

Biology is our software, cells are our cures. Every cell type that we create has the potential to give rise to multiple next generation therapies.

ioCells

Deterministically programmed human iPSC-derived cells for research and drug discovery

iocells_vial_radial_0

Latest news

bit.bio expands Executive Team with appointment of Przemek Obloj as Chief Financial Officer board leadership
bit.bio expands Executive Team with appointment of Przemek Obloj as Chief Financial Officer 31.07.2024
Published by bit.bio
Read now
bit.bio launches 16 disease models for neurodegenerative disease Press Release
bit.bio launches 16 disease models for neurodegenerative disease 24.07.2024
Published by bit.bio
Read now
Sustainability Report Article
Sustainability Report 12.07.2024
Published by bit.bio
Read now
bit.bio CEO featured by excedr on exclusive 4-part podcast series Podcast
bit.bio CEO featured by excedr on exclusive 4-part podcast series 11.07.2024
Published by Excedr
Read now